Is TKCPF or MRK a better dividend investment in 2026?

TKCPF currently yields 3.34% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: TKCPF offers higher current income.

What is the dividend yield difference between TKCPF and MRK?

TKCPF has a forward dividend yield of 3.34% ($2.01/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 0.09 percentage points.

Home › Compare › TKCPF vs MRK

TKCPF vs MRK: Dividend Comparison 2026

TKCPF yields 3.34% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MRK wins by $5.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

TKCPF

● Live price

3.34%

Share price

$60.00

Annual div

$2.01

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.8K

Annual income

$414.75

Full TKCPF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — TKCPF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TKCPF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TKCPF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TKCPF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TKCPF

Annual income on $10K today (after 15% tax)

$284.27/yr

After 10yr DRIP, annual income (after tax)

$352.54/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, MRK beats the other by $455.21/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TKCPF + MRK for your $10,000?

TKCPF: 50%MRK: 50%

100% MRK50/50100% TKCPF

Portfolio after 10yr

$27.8K

Annual income

$682.52/yr

Blended yield

2.46%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TKCPF

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TKCPF buys

MRK buys

Politician	Chamber	Ticker	Type	Amount	Date
Josh Gottheimer	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2026-02-04
Michael McCaul	🏢 House	$MRK	▼ Sell	$15,001 - $50,000	2026-01-13
Gilbert Cisneros	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-12-19
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-12-18
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-11-13
Ro Khanna	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-09-29
Val Hoyle	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-09-23
Marjorie Taylor Greene	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-08-28
Julie Johnson	🏢 House	$MRK	▼ Sell	$1,001 - $15,000	2025-08-14
Gilbert Cisneros	🏢 House	$MRK	▲ Buy	$1,001 - $15,000	2025-08-05

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTKCPFMRK

Forward yield	3.34% ✓	3.25%
Annual dividend / share	$2.01	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$24.8K	$30.7K ✓
Annual income after 10y	$414.75	$950.29 ✓
Total dividends collected	$3.8K	$6.1K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: TKCPF vs MRK ($10,000, DRIP)

Year	TKCPF Portfolio	TKCPF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$11,034	$334.44	$11,192	$351.54	$158.00 → MRK
2	$12,152	$344.89	$12,524	$392.70	$372.00 → MRK
3	$13,357	$354.96	$14,015	$438.65	$658.00 → MRK
4	$14,657	$364.65	$15,682	$489.96	$1.0K → MRK
5	$16,057	$373.96	$17,547	$547.23	$1.5K → MRK
6	$17,564	$382.88	$19,632	$611.16	$2.1K → MRK
7	$19,185	$391.41	$21,963	$682.53	$2.8K → MRK
8	$20,927	$399.56	$24,571	$762.18	$3.6K → MRK
9	$22,799	$407.34	$27,486	$851.08	$4.7K → MRK
10	$24,810	$414.75	$30,745	$950.29	$5.9K → MRK

TKCPF vs MRK: Complete Analysis 2026

TKCPF — Stock

De VanEck Vectors Morningstar Developed Markets Dividend Leaders UCITS ETF is een exchange traded fund (ETF) dat tot doel heeft het zo nauwkeurig mogelijk volgen van de Morningstar Developed Markets Large Cap Dividend Leaders Index (bruto herbeleggingsindex)

Full TKCPF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this TKCPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TKCPF vs SCHD TKCPF vs JEPI TKCPF vs O TKCPF vs KO TKCPF vs MAIN TKCPF vs JNJ TKCPF vs ABBV TKCPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.